You are here » Home » Companies » Company Overview » Sanofi India Ltd

Sanofi India Ltd.

BSE: 500674 Sector: Health care
NSE: SANOFI ISIN Code: INE058A01010
BSE 00:00 | 04 Dec 7896.70 -3.50
(-0.04%)
OPEN

7930.00

HIGH

7940.00

LOW

7866.15

NSE 00:00 | 04 Dec 7899.90 0.30
(0.00%)
OPEN

7948.45

HIGH

7948.45

LOW

7860.55

OPEN 7930.00
PREVIOUS CLOSE 7900.20
VOLUME 13107
52-Week high 8999.00
52-Week low 5900.05
P/E 35.26
Mkt Cap.(Rs cr) 18,186
Buy Price 7895.00
Buy Qty 1.00
Sell Price 7916.00
Sell Qty 2.00
OPEN 7930.00
CLOSE 7900.20
VOLUME 13107
52-Week high 8999.00
52-Week low 5900.05
P/E 35.26
Mkt Cap.(Rs cr) 18,186
Buy Price 7895.00
Buy Qty 1.00
Sell Price 7916.00
Sell Qty 2.00

Sanofi India Ltd. (SANOFI) - Chairman Speech

Company chairman speech

Dear Shareholders

The world stands united today in its fight to protect life from the fast-spreadingimpact of COVID-19. The Sanofi group worldwide is fully engaged in the critical task ofaccelerating the development and availability of potential treatments to fight thisinfection. Even as you read this edition of our Annual Report your Company is at theforefront of the mission to ensure uninterrupted supplies of essential medicines acrossIndia.

Putting duty before self employees at all our factories and sites continue to reportto work ensuring that we manufacture at maximum possible capacity while being fullycompliant with COVID-19-related safety measures. At the same time other employees havebeen working from home since mid-March 2020 to stay safe and conform to the lockdownguidelines. Our significant investments in technology and digital capabilities over thelast few years have enabled employees to transition smoothly to working remotely andstaying connected with key stakeholders. We remain fully committed to making a realdifference to the lives of millions of patients every day even as we prepare for the newnormal.

While the recent onslaught of the Coronavirus has clouded every other conceivablehealth hazard that modern times have witnessed the burden of many other diseasescontinues to rise in India. The alarming rise in non-communicable diseases has putsignificant pressure on our healthcare system.

Your Company is steering well through this ecosystem with strong planning sharpexecution and future-focused initiatives which keep patients at the center of everythingwe do. Overall we continue to grow in line with the market often delivering double-digitgrowth in key therapies. Along with empowering patients with the assurance ofbest-in-class medication backed by data-driven outcomes we now also build solutionsaround the treatment - like counselling education and creating awareness for earlydiagnosis and better disease management. Our world-class manufacturing facilities andsupply chain have stretched to deliver uninterrupted supply of high-quality medicinesacross the wide geography of India and other countries. A true example of make-in-Indiafor India and for the World. Through all this we remain committed to maintaining thehighest standards of ethics and integrity in all our actions - never hesitating to dowhat's right.

Our world today is being shaped by new technologies which have the potential to trulytransform healthcare. This has received further boost due to the world adapting to digitalcommunication during the lockdown. Advanced decision systems delivery planning toolsintuitive shopping algorithms new learning gadgets and many other applications are nowfinding use thanks to the emergence of artificial intelligence machine learning andblockchain technology. Organisations need to learn adapt and even stay ahead of thesedevelopments to remain relevant. Your Company sees tremendous value in delivering resultsthrough unique digital-first outcome-based initiatives. We are constantly working withour partners to develop efficient and agile processes in order to deliver insights andanalysis. This enables us to empower patients with customised on-demand services. Todayyour Company's sales force has transitioned to using mobile devices which generatereal-time insights and help them have richer deeper and engaging conversations withhealthcare professionals.

At Sanofi we believe that happy people make happy employees. Your Company was awardedthe ‘TOP Employer of 2019' in recognition of its employee practices and work culture.This certification was granted to Sanofi in India and in the Asia-Pacific region. Frommaking policies that are inclusive diverse and gender-balanced to creating opportunitiesfor wellness and volunteering time for community service we stay committed to honing ourtalent and making Sanofi a great place to work.

I cannot thank our employees enough for making Sanofi a company where everyone feelscomfortable safe and free to bring their best selves to work each day. The expertise ofour Board of Directors has been invaluable in steering your Company through thischallenging but rewarding journey.

I reiterate my gratitude to all our shareholders for believing in the potential andpromise of Sanofi. We are inspired by your continued trust and confidence in your Companyand I wish to thank you for your encouragement and support.

2020 is no doubt a hugely challenging year for your Company the industry and for theentire world. During such times our commitment to Empowering Life is furtherstrengthened as it provides each of us the resolve and purpose to bring hope and healthto millions of people.

Wishing your families and you the best of health. Stay safe.

Yours sincerely

Rajaram Narayanan

.